Repeat-positive SARS-CoV-2 in a child with cancer.

Szczegóły
Comments

Tytuł:: Repeat-positive SARS-CoV-2 in a child with cancer.
Autorzy:: Radhakrishnan V; Department of Medical Oncology (Pediatric Oncology Division), Cancer Institute (WIA), Adyar, Chennai, India.
Gangopadhyay D; Department of Medical Oncology (Pediatric Oncology Division), Cancer Institute (WIA), Adyar, Chennai, India.
Źródło:: Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Mar; Vol. 68 (3), pp. e28744. Date of Electronic Publication: 2020 Oct 03.
Typ publikacji:: Letter
Język:: English
Imprint Name(s):: Original Publication: Hoboken, N.J. : John Wiley, c 2004-
MeSH Terms:: Asymptomatic Diseases*
Antimetabolites, Antineoplastic/*therapeutic use
COVID-19/*diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy
Antimetabolites, Antineoplastic/adverse effects ; Child, Preschool ; Humans ; Male ; Mercaptopurine/adverse effects ; Mercaptopurine/therapeutic use ; Methotrexate/adverse effects ; Methotrexate/therapeutic use ; Recurrence ; SARS-CoV-2/genetics
References:: JAMA Pediatr. 2021 Jan 1;175(1):73-80. (PMID: 32857112)
EBioMedicine. 2020 Sep;59:102960. (PMID: 32853988)
Am J Emerg Med. 2021 Jan;39:256.e1-256.e3. (PMID: 32703607)
Colorectal Dis. 2020 Jun;22(6):611-620. (PMID: 32418307)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
J Med Virol. 2021 Jan;93(1):506-512. (PMID: 32644223)
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951. (PMID: 32840608)
New Microbes New Infect. 2020 Sep;37:100748. (PMID: 32843984)
Substance Nomenclature:: 0 (Antimetabolites, Antineoplastic)
E7WED276I5 (Mercaptopurine)
YL5FZ2Y5U1 (Methotrexate)
Entry Date(s):: Date Created: 20201003 Date Completed: 20210208 Latest Revision: 20221005
Update Code:: 20240105
PubMed Central ID:: PMC7646029
DOI:: 10.1002/pbc.28744
PMID:: 33009874
: Opinia redakcyjna

Full Text Finder

Comment in: Pediatr Blood Cancer. 2022 Sep;69(9):e29620. (PMID: 35187774)

Informacja